A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity.

 
Web www.patentalert.com

< [1,4]Diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents

< 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them

> Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto

> Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
~ 00213